Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
Restless legs syndrome heralding an acute exacerbation of multiple sclerosis.
Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.
Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Effect of Smoking Cessation on Multiple Sclerosis Prognosis.
Physician-patient communication skills: e-tools.
Mimics and chameleons of optic neuritis.
MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.
[Pharmacological treatment of spasticity in multiple sclerosis].
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
Multiple Sclerosis Alters the Mechanical Work Performed on the Body's Center of Mass during Gait.
The Challenges for Drug Development: Cytokines, Genes, and Stem Cells.
Inflammation high-field magnetic resonance imaging.
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Could behavioral therapies target specific deficits in multiple sclerosis patients?
MRI correlates of disability in african-americans with multiple sclerosis.
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study.
The role of complement in neurological and neuropsychiatric diseases.
Pages
« first
‹ previous
…
265
266
267
268
269
270
271
272
273
…
next ›
last »